ly 300164 has been researched along with diazepam in 1 studies
| Studies (ly 300164) | Trials (ly 300164) | Recent Studies (post-2010) (ly 300164) | Studies (diazepam) | Trials (diazepam) | Recent Studies (post-2010) (diazepam) |
|---|---|---|---|---|---|
| 73 | 7 | 12 | 18,377 | 2,329 | 1,790 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowicz, KK; Czuczwar, SJ; Kleinrok, Z | 1 |
1 other study(ies) available for ly 300164 and diazepam
| Article | Year |
|---|---|
The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam.
Topics: Amygdala; Animals; Anticonvulsants; Behavior, Animal; Benzodiazepines; Diazepam; Drug Interactions; Drug Synergism; Electroshock; Excitatory Amino Acid Antagonists; Kindling, Neurologic; Male; Mice; Pentylenetetrazole; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Kainic Acid; Seizures | 2000 |